J. Patrick Finn
J. Patrick Finn is a Principal in the Twin Cities office of Fish & Richardson. His practice emphasizes patent preparation and prosecution, strategic portfolio management, patentability and freedom-to-operate searching and analysis, reexamination proceedings, opinions, due diligence investigations, licensing and counseling in the medical biotechnology, agricultural biotechnology, diagnostic, pharmaceutical, and medical science fields.
His projects have involved subject matter such as novel genes, antibodies, gene therapies, vaccines, antisense therapeutics, RNA interference therapeutics, stem cells, transgenic plants, transgenic animals, proteomics, transcription factors, regulator elements, cell culture techniques, high-throughput screening assays, diagnostic assays and agents, microarrays, medical devices, and potential treatments for diseases such as cardiovascular disease, cancer, allergy, arthritis, diabetes, and Alzheimer’s Disease. Dr. Finn works with universities, pharmaceutical companies, medical device companies, investment firms, and emerging and established companies in the field of biotechnology.
His licensing experience includes university/industry collaborations, patent out-licensing and in-licensing programs, and joint ventures.
As a PhD candidate at the University of California, Los Angeles, Dr. Finn acquired extensive experience in molecular and cellular biology. In particular, he regularly performed molecular cloning and protein purification techniques as well as analytical activity assays such as transport assays designed to measure neurotransmitter transport into vesicles. One focus of Dr. Finn’s graduate work involved a structural and functional characterization of vesicular transport proteins such as the vesicular monoamine transporters (VMATs).
J.D., William Mitchell College of Law 2002
Ph.D., University of California, Los Angeles 1997
Microbiology and Immunology
B.S., Pennsylvania State University 1991
- U.S. Patent and Trademark Office 1999
- Minnesota 2002
“Intellectual property 101,” Med. Sci. Monit., 2005 Nov;11(11):ED7.
“Patents 101,” Med. Sci. Monit., 2005 Dec;11(12):ED9-10.
Co-author of numerous scientific publications, including:
“Analysis of neurotransmitter transport into secretory vesicles,” Methods of Enzymology, 1998; 296: 144-62.
“Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2,” J. Biol. Chem., 1998 Feb. 13, 273(7): 3943-3947.
“Ligand recognition by the vesicular monoamine transporters,” Advances of Pharmacology, 1998, 42: 232-236.
“Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2,” J. Biol. Chem., 1997 Jun. 27, 272(26): 16301-16307.
“Molecular analysis of serotonin packaging into secretory vesicles,” In Handbook of Experimental Pharmacology, 1997, 131-152.
Recipient of UCSF/NIH Physiology Training Grant (1995-1996) and UCLA/NIH Neuroscience Training Grant (1992-1994).
Selected as a 2012 Super Lawyers Rising Star.